Variant report
Variant | nsv9094 |
---|---|
Chromosome Location | chr13:85567525-85572204 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570716373 | chr13:85567602-85567603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs9547030 | chr13:85567636-85567637 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs145784698 | chr13:85567644-85567645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550169128 | chr13:85567660-85567661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192049359 | chr13:85567663-85567664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs535927517 | chr13:85567664-85567665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs377126203 | chr13:85567726-85567727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs9531697 | chr13:85567749-85567750 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs551614488 | chr13:85567787-85567788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs557279289 | chr13:85567853-85567854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs76541603 | chr13:85567933-85567934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs2496761 | chr13:85567946-85567947 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs539684629 | chr13:85567995-85567996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557939846 | chr13:85568025-85568026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138367419 | chr13:85568048-85568049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs377391106 | chr13:85568051-85568052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12583714 | chr13:85568086-85568087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574386443 | chr13:85568088-85568089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs541888544 | chr13:85568136-85568137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs183438314 | chr13:85568188-85568189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs9531698 | chr13:85568190-85568191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552351915 | chr13:85568202-85568203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564292632 | chr13:85568232-85568233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12585294 | chr13:85568235-85568236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs187759160 | chr13:85568239-85568240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs568441802 | chr13:85568244-85568245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535525541 | chr13:85568250-85568251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs71210944 | chr13:85568259-85568260 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs565999432 | chr13:85568262-85568263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs12584582 | chr13:85568263-85568264 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs184446690 | chr13:85568264-85568265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs12583725 | chr13:85568265-85568266 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs537333924 | chr13:85568268-85568269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs555670179 | chr13:85568269-85568270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574373401 | chr13:85568273-85568274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs189379220 | chr13:85568274-85568275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs56745729 | chr13:85568275-85568276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543975414 | chr13:85568284-85568285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs376025428 | chr13:85568287-85568288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs550789058 | chr13:85568293-85568294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531562843 | chr13:85568301-85568302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562494482 | chr13:85568309-85568310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs543736650 | chr13:85568312-85568313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs561874002 | chr13:85568323-85568324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141403279 | chr13:85568327-85568328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9531699 | chr13:85568330-85568331 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs566483380 | chr13:85568334-85568335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs527271183 | chr13:85568337-85568338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184855742 | chr13:85568338-85568339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs56672550 | chr13:85568340-85568341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 19490664 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:85567600-85568000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr13:85568000-85568400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr13:85568400-85569200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr13:85568600-85568800 | Enhancers | A549 | lung |
5 | chr13:85568600-85569400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
6 | chr13:85568600-85569400 | Enhancers | Stomach Mucosa | stomach |
7 | chr13:85568800-85569200 | Active TSS | A549 | lung |
8 | chr13:85569000-85569400 | Enhancers | HepG2 | liver |
9 | chr13:85569200-85569400 | Flanking Active TSS | A549 | lung |